×
戻る Agenda
Session4:Realizing the True Value of the Conditional and Time-Limited Approval System
Session Chair(s)
Akihiro Kume
Advisor, Corporate Planning Office
RPM Co., Ltd, Japan
Mizuho Nonaka
Associate Director, Development Regulatory Affairs, Drug Development Division
Sumitomo Pharma Co., Ltd., Japan
Speaker(s)
Atsushi Nishikawa
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of Cellular and Tissue-based Products
Kazumi Sawaguchi, PHD
Sanbio Co. Ltd., Japan
Corporate Officer, Head of Regulatory Affairs and Quality Compliance
Makiko Okada
Chugai Pharmaceutical Co., Ltd., Japan
Specialty Clinical Development Dept.
Kazuhisa Senshu
Terumo Corporation, Japan
Advisor